A. Salazar

S. L. Stevens, M. Stenzel-Poore, J. Hedges, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

Susan M. Chang, M. Prados, M. Mehta, 2008, Journal of Neuro-Oncology.

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

R. Steinman, M. Colonna, A. Salazar, 2009, The Journal of experimental medicine.

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.

S. Hoffman, R. Steinman, M. Nussenzweig, 2010, Vaccine.

Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells

John P. Moore, Magdalini Moutaftsi, S. Reed, 2013, PloS one.

CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice.

R. Steinman, A. Salazar, C. Münz, 2013, Blood.

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)

Susan M. Chang, M. Prados, L. Deangelis, 2008, Journal of Neuro-Oncology.

Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events

O. Caballero, A. Salazar, M. Dagli, 2021, Cancers.

A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.

T. Batchelor, M. Chamberlain, M. Rosenfeld, 2010, Neuro-oncology.

Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs.

A. Salazar, M. E. Christopher, J. Wong, 2005, Vaccine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses.

A. Salazar, M. E. Christopher, J. Wong, 2007, Vaccine.

Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment

J. L. Ding, E. C. Su, Shu-Chun Chang, 2021, International journal of molecular sciences.

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

M. Merad, T. Marron, Adeeb H. Rahman, 2019, Nature Medicine.

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

I. Melero, M. Rodriguez-Ruiz, J. Pérez-Gracia, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

I. Castaneda, A. Salazar, S. Gonzales, 2017, Journal of hepatocellular carcinoma.

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

R. Schoen, A. Salazar, O. Finn, 2012, Cancer Prevention Research.

HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates

Y. Lévy, A. Salazar, R. Thiébaut, 2018, PloS one.

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells

R. Ferris, A. Salazar, Chwee Ming Lim, 2013, Oncoimmunology.

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets

P. Danaher, D. Bedognetti, J. Beechem, 2020, Nature Cancer.

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

A. Sher, D. Barber, A. Salazar, 2014, Nature.

Use of the Antiviral and Immune Modulator, Poly (ICLC), in the Treatment of AIDS

A. Salazar, H. Levy, 1991 .

Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein

O. Caballero, R. Gazzinelli, S. Ramos, 2021, bioRxiv.

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

S. Self, D. Montefiori, R. Gottardo, 2017, Journal of Virology.

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

H. Sultan, A. Salazar, E. Celis, 2019, Cancer Immunology, Immunotherapy.

Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy

A. Salazar, J. Ohlfest, A. Dudek, 2013, The Journal of Immunology.

The efficacy of poly‐ICLC against Ebola‐Zaire virus (EBOV) infection in mice and cynomolgus monkeys

M. Kende, A. Salazar, J. Paragas, 2019, Antiviral research.

Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.

A. Salazar, T. de los Santos, M. Grubman, 2014, Virology.

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

P. Sabbatini, L. Old, C. Aghajanian, 2012, Clinical Cancer Research.

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation

Samuel P. Dickson, J. Dye, S. Bavari, 2014, PloS one.

Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model

A. Salazar, J. Ohlfest, A. Litterman, 2013, The Journal of Immunology.

Tumor in a Murine Glioma Model Primed as a Function of Proximity to the and Quantitative Defects in CD8 T Cells Vaccine Injection Site Matters: Qualitative

A. Salazar, J. Ohlfest, A. Litterman, 2012 .

This information is current as Tumor in a Murine Glioma Model Primed as a Function of Proximity to the and Quantitative Defects in CD 8 T Cells Vaccine Injection Site Matters : Qualitative

A. Salazar, J. Ohlfest, A. Litterman, 2012 .

Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

P. Ott, A. Pavlick, M. Meseck, 2019, Cancer Immunology Research.

Double-Stranded RNA Immunomodulators in Prostate Cancer.

A. Salazar, E. Celis, 2020, The Urologic clinics of North America.

Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma

Charles H. Yoon, Shuqiang Li, N. Lennon, 2018, Nature.

Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.

M. Prados, L. Butterfield, J. Villanueva-Meyer, 2020, The Journal of clinical investigation.

Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung

Michael J. Davis, S. Seyedmousavi, A. Salazar, 2018, mBio.

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.

D. Levy, N. Bhardwaj, A. Salazar, 2011, Cancer research.

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein

R. Gazzinelli, S. Ramos, J. Kalil, 2022, Nature Communications.

Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non‐human primates

S. Kent, A. Salazar, A. Brooks, 2015, European journal of immunology.

Complete Dependence on IRAK4 Kinase Activity in TLR2, but Not TLR4, Signaling Pathways Underlies Decreased Cytokine Production and Increased Susceptibility to Streptococcus pneumoniae Infection in IRAK4 Kinase–Inactive Mice

S. Vogel, M. Lipsky, A. Salazar, 2013, The Journal of Immunology.

Production and Increased Susceptibility to Pathways Underlies Decreased Cytokine Activity in TLR2, but Not TLR4, Signaling Complete Dependence on IRAK4 Kinase

S. Vogel, M. Lipsky, A. Salazar, 2012 .

Inactive Mice − IRAK 4 Kinase Infection in Streptococcus pneumoniae Production and Increased Susceptibility to Pathways Underlies Decreased Cytokine Activity in TLR 2 , but Not TLR 4 , Signaling Complete Dependence on IRAK 4 Kinase

S. Vogel, M. Lipsky, A. Salazar, 2012 .

Neutralizing antibody-independent immunity to SARS-CoV-2 in Syrian hamsters and human ACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein

R. Gazzinelli, S. Ramos, J. Kalil, 2021 .

Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy.

J. Lifson, J. Bess, N. Bhardwaj, 2015, Vaccine.

Running title : CSP and Adjuvants Induce Antibody Mediated Protection

Stoyanov, C. Ockenhouse, A. Salazar, 2012 .

IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity

H. Okada, A. Salazar, T. Ohkuri, 2021, Journal for ImmunoTherapy of Cancer.

Cytosolic Receptor Melanoma Differentiation–Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury

S. L. Stevens, M. Stenzel-Poore, A. Salazar, 2016, Stroke.

Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma

A. Salazar, C. Lim, Nagaraja Rao Gangodu, 2018, Oncoimmunology.

Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.

A. Salazar, M. E. Christopher, J. Wong, 2009, Current pharmaceutical design.

Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates.

K. Foulds, A. Salazar, J. Moon, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy

A. Salazar, J. Ohlfest, A. Dudek, 2013, The Journal of Immunology.

Novel antiviral therapeutics to control foot-and-mouth disease.

A. Salazar, T. de los Santos, M. Grubman, 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants.

P. Walker, F. Cerini, H. Gaertner, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners

Edward R. Kastenhuber, H. Okada, A. Salazar, 2010, Cancer Immunology, Immunotherapy.

Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors

T. MacDonald, S. Vandenberg, D. Durden, 2014, Journal of pediatric hematology/oncology.

Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.

Daniel E. Zak, Carrie D. Johnson, D. Zak, 2017, Blood advances.

Vaccine adjuvant uses of poly-IC and derivatives

S. Bavari, A. Salazar, K. Martins, 2015, Expert review of vaccines.

Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza.

M. Cairns, Lunquan Sun, E. Saravolac, 2010, Frontiers in bioscience.

An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Flavia E. Popescu, M. G. O’Sullivan, A. Epstein, 2012, Clinical Cancer Research.

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

R. Steinman, R. Sékaly, M. Cameron, 2011, The Journal of experimental medicine.

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

A. D. De Groot, B. McGonnigal, A. Salazar, 2021, NPJ vaccines.

Mucosal immune stimulation with HSV-2 and polyICLC boosts control of viremia in SIVΔNef vaccinated rhesus macaques with breakthrough SIV infection

A. Gettie, J. Blanchard, J. Lifson, 2020, bioRxiv.

Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial

M. Markowitz, H. Mohri, N. Bhardwaj, 2019, Front. Immunol..

Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial

W. Loging, P. Friedlander, T. Thin, 2018, Clinical Cancer Research.

Designing therapeutic cancer vaccines by mimicking viral infections

H. Sultan, A. Salazar, E. Celis, 2017, Cancer Immunology, Immunotherapy.

PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo

A. Gettie, J. Blanchard, J. Lifson, 2016, PloS one.

A Dendritic cell targeted vaccine induces long term HIV-specific immunity within the gastrointestinal tract

S. Mehandru, A. Salazar, M. Caskey, 2016, Mucosal Immunology.

Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

A. Salazar, K. Matsuo, L. Roman, 2015, Clinical immunology.

Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis

D. Barber, E. Sionov, A. Salazar, 2015, PLoS pathogens.

Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C

A. Salazar, Joseph G Skeate, Julia R. Taylor, 2015, Papillomavirus research.

Nucleic acid-based drugs for eliciting a host’s innate immunity against viral diseases

A. Salazar, J. Wong, 2013 .

Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial

P. Sabbatini, D. Spriggs, S. Gnjatic, 2013, Cancer Immunology Research.

Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses.

P. Hwu, Zhi-Ying Chen, A. Salazar, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

R. Steinman, K. Überla, P. Rácz, 2009, PLoS pathogens.

Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.

M. Prados, L. Butterfield, J. Villanueva-Meyer, 2022, The Journal of clinical investigation.

Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

J. Engh, E. Shaw, F. Lieberman, 2014, Clinical Cancer Research.

Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice

H. Sultan, A. Salazar, E. Celis, 2018, Cancer Immunology, Immunotherapy.

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas

Jennie W. Taylor, Susan M. Chang, P. Theodosopoulos, 2021, The Journal of clinical investigation.

Immunologic Characterization of a Rhesus Macaque H1N1 Challenge Model for Candidate Influenza Virus Vaccine Assessment

Jason A. Skinner, M. Kuroda, R. Albrecht, 2014, Clinical and Vaccine Immunology.

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

A. Salazar, M. E. Christopher, J. Wong, 2009, Vaccine.

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer

M. Thomas, M. Nishimura, S. Mehrotra, 2017, Journal of Hematology & Oncology.

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4

M. Beltramello, U. Baxa, J. Mascola, 2018, Proceedings of the National Academy of Sciences.

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus

J. Mascola, G. Chuang, M. Sastry, 2017, PloS one.

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

A. Sher, A. Salazar, C. Feng, 2010, The Journal of clinical investigation.

A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation

A. Gettie, J. Lifson, M. Piatak, 2010, PloS one.

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

Junichi Eguchi, Wendy Fellows-Mayle, Xinmei Zhu, 2007, Journal of Translational Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.

Haiyan Chen, Laura L. Sutherland, B. Haynes, 2017, Cell reports.

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.

P. Walker, D. Martinvalet, M. Derouazi, 2015, Cancer research.

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates

R. Steinman, G. Pantaleo, R. Wagner, 2011, Proceedings of the National Academy of Sciences.

Activating the Natural Host Defense Poly-ICLC and Malignant Brain Tumors

A. Salazar, 2003 .

Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+ T Cell Immunity and Protection in Mice

C. Ockenhouse, A. Salazar, R. Seder, 2012, Infection and Immunity.

Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

B. Levine, M. Kalos, C. June, 2013, Clinical Cancer Research.

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

M. Merad, T. Marron, Adeeb H. Rahman, 2019, Nature Medicine.

Induction of Interferon-γ-Inducible Protein 10 by SARS-CoV Infection, Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice

Jason R. Madsen, D. Smee, A. Salazar, 2010, Antiviral chemistry & chemotherapy.

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia

Yusuke Nakamura, R. Larson, Jae-Hyun Park, 2018, Experimental Hematology & Oncology.

Protection in Mice T Cell Immunity and + Antibody and CD4 Adjuvant-Stable Emulsion Elicits Potent Receptor 4 Agonist Glucopyranosyl Lipid with Long-Chain Poly(I·C) or the Toll-Like Circumsporozoite Protein Administered Full-Length Plasmodium falciparum

C. Ockenhouse, A. Salazar, R. Seder, 2014 .

Risk of Immunodeficiency Virus Infection May Increase with Vaccine-Induced Immune Response

K. Überla, A. Salazar, M. Tenbusch, 2012, Journal of Virology.

In situ vaccine for low-grade lymphoma: Combination of intratumoral Flt3L and poly-ICLC with low-Dose radiotherapy.

S. Kim-Schulze, T. Marron, N. Bhardwaj, 2015 .

PDCT-03. A PHASE II TRIAL OF POLY-ICLC IN THE MANAGEMENT OF RECURRENT OR PROGRESSIVE PEDIATRIC LOW GRADE GLIOMAS. RESULTS FOR THE NEUROFIBROMATOSIS 1 GROUP. (NCT01188096)

T. MacDonald, D. Durden, R. Castellino, 2018, Neuro-Oncology.

Characterization of Peripheral and Mucosal Immune Responses In Rhesus Macaques on Long-Term Tenofovir and Emtricitabine Combination Antiretroviral Therapy

A. Gettie, J. Lifson, M. Piatak, 2012, Journal of acquired immune deficiency syndromes.

Poly ICLC in the treatment of postinfectious demyelinating encephalomyelitis.

W. Engel, A. Salazar, H. Levy, 1981, Archives of neurology.

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease

C. Carneiro, R. Gazzinelli, A. B. Reis, 2023, NPJ vaccines.

Title: Full-length P. Falciparum Circumsporozoite Protein

C. Ockenhouse, A. Salazar, R. Seder, 2012 .

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

R. Herndon, R. Rudick, J. Simon, 1998, Neurology.

Use of low-dose cyclophosphaminde followed by low-dose tumoral radiation, intratumoral poly-ICLC combined with local-regional therapy, followed by systemic immune boosting with intramuscular poly-ICLC in patients with cancers of the liver.

A. Salazar, S. Contractor, Ismael Castaneda, 2015 .

Real-Time Nucleic Acid Sequence-Based Amplification Assay for Detection of Hepatitis A Virus

Wilfred Chen, A. Mulchandani, M. Yates, 2005, Applied and Environmental Microbiology.

Evaluation of Interferon Inducers, Ribavirin and Mouse Hyperimmune Serum in a Pathogenesis/Lethal Mouse Model Using a Mouse-adapted SARS-CoV

A. Salazar, D. Barnard, M. Wandersee, 2008, Antiviral Research.

Combining In Situ Vaccination with Immune Checkpoint Blockade Induces Long-Term Regression of Lymphoma Tumors

A. Salazar, J. Brody, T. Keler, 2016 .

Visualization and Detection of Infectious Coxsackievirus Replication Using a Combined Cell Culture-Molecular Beacon Assay

Wilfred Chen, A. Mulchandani, M. Yates, 2005, Applied and Environmental Microbiology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

A. Sher, A. Salazar, C. Feng, 2010, The Journal of clinical investigation.

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Alyssa R. Richman, Monika S. Kowalczyk, Shuqiang Li, 2018, Nature.

Poly-IC Preconditioning Protects against Cerebral and Renal Ischemia-Reperfusion Injury

S. L. Stevens, M. Stenzel-Poore, J. Hedges, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

B. Levine, M. Kalos, C. June, 2013, Clinical Cancer Research.

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

R. Steinman, M. Colonna, A. Salazar, 2009, The Journal of experimental medicine.

Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]

M. Merad, S. Kim-Schulze, N. Bhardwaj, 2014, Journal of Immunotherapy for Cancer.